{"id":20652,"date":"2018-06-27T08:30:33","date_gmt":"2018-06-27T15:30:33","guid":{"rendered":"https:\/\/insidebigdata.com\/?p=20652"},"modified":"2018-06-28T08:49:27","modified_gmt":"2018-06-28T15:49:27","slug":"ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days","status":"publish","type":"post","link":"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/","title":{"rendered":"AI for Pharma R&#038;D &#8211; Creating Anti-cancer Drugs Faster, Reducing Process from Years to Days"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\"alignright size-full wp-image-20653\" src=\"https:\/\/insidebigdata.com\/wp-content\/uploads\/2018\/06\/AccutarBio_logo.png\" alt=\"\" width=\"162\" height=\"67\" srcset=\"https:\/\/insidebigdata.com\/wp-content\/uploads\/2018\/06\/AccutarBio_logo.png 162w, https:\/\/insidebigdata.com\/wp-content\/uploads\/2018\/06\/AccutarBio_logo-150x62.png 150w\" sizes=\"(max-width: 162px) 100vw, 162px\" \/>The costs and process of developing anti-cancer drugs has been an extreme challenge for decades. Today one company, <a href=\"https:\/\/www.accutarbio.com\/\" target=\"_blank\" rel=\"noopener\" data-saferedirecturl=\"https:\/\/www.google.com\/url?hl=en&amp;q=http:\/\/track.hottomato.net\/y.z?l%3Dhttps%253a%252f%252fwww.accutarbio.com%252fabout%252f%26j%3D325801056%26e%3D114%26p%3D1%26t%3Dh%26C4937C1D05374BE59B503DE48AD53E6C&amp;source=gmail&amp;ust=1530150858210000&amp;usg=AFQjCNE2oFwE51sgXPlIDi2TFdgtgDs_JQ\">AccutarBio<\/a>, is harnessing the power of AI to accelerate drug discovery and reform the current &#8220;hit-to-lead&#8221; drug discovery scheme. The company recently received $15 million in funding (including money from Chinese AI\/facial recognition company YITU) and is now partnering with Amgen.<\/p>\n<p>AccutarBio is proud of the dramatic improvements the company\u2019s hybrid approach (combining computation design and experimental validation) has made in radically speeding up the drug discovery process. The company has achieved thus far:<\/p>\n<ul>\n<li>A data-driven atom-based scoring function is learned from 100,000 protein crystal structures containing information of &gt;100 million amino acid side chains.<\/li>\n<li>A dynamic deep neural network specifically designed for chemical informatics.<\/li>\n<\/ul>\n<p>The video below demonstrates how the company&#8217;s Orbital docking and virtual screen works.<\/p>\n<div class=\"embed-vimeo\" style=\"text-align: center;\"><iframe loading=\"lazy\" src=\"https:\/\/player.vimeo.com\/video\/272702382\" width=\"600\" height=\"338\" frameborder=\"0\" webkitallowfullscreen mozallowfullscreen allowfullscreen><\/iframe><\/div>\n<p>AccutarBio uses AI technology to explain the physical and chemical nature of biological systems to accelerate drug discoveries.\u00a0 This drastically reduces the traditional drug screening process of extensive experimentation at the cost of billions of dollars so that work that took two years previously can be done in a matter of hours.<\/p>\n<div id=\"attachment_20654\" style=\"width: 565px\" class=\"wp-caption aligncenter\"><img aria-describedby=\"caption-attachment-20654\" decoding=\"async\" loading=\"lazy\" class=\" wp-image-20654\" src=\"https:\/\/insidebigdata.com\/wp-content\/uploads\/2018\/06\/AccutarBio_image.png\" alt=\"\" width=\"555\" height=\"280\" srcset=\"https:\/\/insidebigdata.com\/wp-content\/uploads\/2018\/06\/AccutarBio_image.png 700w, https:\/\/insidebigdata.com\/wp-content\/uploads\/2018\/06\/AccutarBio_image-300x151.png 300w, https:\/\/insidebigdata.com\/wp-content\/uploads\/2018\/06\/AccutarBio_image-150x76.png 150w\" sizes=\"(max-width: 555px) 100vw, 555px\" \/><p id=\"caption-attachment-20654\" class=\"wp-caption-text\">Overall network architecture<\/p><\/div>\n<p><strong>Artificial Intelligence for Drug Discovery<\/strong><\/p>\n<p>Accutarbio&#8217;s AI platform outperforms current standard approach in multiple tasks in drug discovery including: drug pocket prediction, drug-target complex conformation prediction, drug-target binding affinity prediction and drug property (ADME) prediction etc. The company&#8217;s virtual screen could potentially replace the need for costly experiment based screens; the docking pose prediction potentially saves the efforts for crystallization; and Chemi-Net could guide compound optimization\/sampling more efficiently. Most importantly, the company proposes an integrated use the platform in pre-clinical research that will greatly improve drug discovery efficiency amounting to potentially saving 80% of the cost and accelerate the discovery cycle significantly.<\/p>\n<p>At present, the screening of target drugs is often completed through a large number of experiments, and this process is often measured in years. For pharmaceutical companies with patents that are generally only valid for 17 years, it is common that R&amp;D takes about 12-13 years. The annual economic benefits brought about by early completion of experiments are likely to be in the hundreds of millions or even billions of dollars. AccutarBio found that much pre-clinical research can be replaced in the form of AI algorithms, and the time spent can also be reduced from years to months, days, or even hours. AccutarBio has trained an AI algorithm based on more than 100,000 crystallographic data to accurately predict the target-binding potential of chemical compounds, screen lead compounds, and even in silicon design the compound for some biological function.<\/p>\n<p>Dr. Fan Jie, founder of AccutarBio, predicts that through this platform, R&amp;D that otherwise takes two years or so can be completed in a matter of hours. AccutarBio has used this platform for drug design. AccutarBio has obtained proof of concept results for multiple targets. Some of the leading compounds have been validated by different experiments including crystallography and animal studies.<\/p>\n<p><strong>Current Research<\/strong><\/p>\n<p>AccutarBio researchers have a number of papers on the arXiv pre-print server. Specifically:<\/p>\n<ul>\n<li>\u00a0<a href=\"https:\/\/arxiv.org\/abs\/1803.06236\" target=\"_blank\" rel=\"noopener\">Chemi-Net: A molecular graph convolutional network for accurate drug property prediction<\/a> &#8211; The research results showed that the deep neural network method used improved current methods by a large margin.<\/li>\n<li>\u00a0<a href=\"https:\/\/arxiv.org\/abs\/1707.08381\" target=\"_blank\" rel=\"noopener\">Prediction of amino acid side chain conformation using a deep neural network<\/a> &#8211; A deep neural network based architecture was constructed to predict amino acid side chain conformation with unprecedented accuracy.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><em>Sign up for the free insideBIGDATA\u00a0<a href=\"http:\/\/insidebigdata.com\/newsletter\/\" target=\"_blank\" rel=\"noopener\">newsletter<\/a>.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The costs and process of developing anti-cancer drugs has been an extreme challenge for decades. Today one company, AccutarBio, is harnessing the power of AI to accelerate drug discovery and reform the current &#8220;hit-to-lead&#8221; drug discovery scheme. The company recently received $15 million in funding (including money from Chinese AI\/facial recognition company YITU) and is now partnering with Amgen.<\/p>\n","protected":false},"author":10513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"categories":[526,87,180,74,122,56,76,84,1],"tags":[324,615,652,96],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AI for Pharma R&amp;D - Creating Anti-cancer Drugs Faster, Reducing Process from Years to Days - insideBIGDATA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AI for Pharma R&amp;D - Creating Anti-cancer Drugs Faster, Reducing Process from Years to Days - insideBIGDATA\" \/>\n<meta property=\"og:description\" content=\"The costs and process of developing anti-cancer drugs has been an extreme challenge for decades. Today one company, AccutarBio, is harnessing the power of AI to accelerate drug discovery and reform the current &quot;hit-to-lead&quot; drug discovery scheme. The company recently received $15 million in funding (including money from Chinese AI\/facial recognition company YITU) and is now partnering with Amgen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/\" \/>\n<meta property=\"og:site_name\" content=\"insideBIGDATA\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/insidebigdata\" \/>\n<meta property=\"article:published_time\" content=\"2018-06-27T15:30:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-06-28T15:49:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/insidebigdata.com\/wp-content\/uploads\/2018\/06\/AccutarBio_logo.png\" \/>\n<meta name=\"author\" content=\"Editorial Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@insideBigData\" \/>\n<meta name=\"twitter:site\" content=\"@insideBigData\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editorial Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/\",\"url\":\"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/\",\"name\":\"AI for Pharma R&D - Creating Anti-cancer Drugs Faster, Reducing Process from Years to Days - insideBIGDATA\",\"isPartOf\":{\"@id\":\"https:\/\/insidebigdata.com\/#website\"},\"datePublished\":\"2018-06-27T15:30:33+00:00\",\"dateModified\":\"2018-06-28T15:49:27+00:00\",\"author\":{\"@id\":\"https:\/\/insidebigdata.com\/#\/schema\/person\/2949e412c144601cdbcc803bd234e1b9\"},\"breadcrumb\":{\"@id\":\"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/insidebigdata.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AI for Pharma R&#038;D &#8211; Creating Anti-cancer Drugs Faster, Reducing Process from Years to Days\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/insidebigdata.com\/#website\",\"url\":\"https:\/\/insidebigdata.com\/\",\"name\":\"insideBIGDATA\",\"description\":\"Your Source for AI, Data Science, Deep Learning &amp; Machine Learning Strategies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/insidebigdata.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/insidebigdata.com\/#\/schema\/person\/2949e412c144601cdbcc803bd234e1b9\",\"name\":\"Editorial Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/insidebigdata.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e137ce7ea40e38bd4d25bb7860cfe3e4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e137ce7ea40e38bd4d25bb7860cfe3e4?s=96&d=mm&r=g\",\"caption\":\"Editorial Team\"},\"sameAs\":[\"http:\/\/www.insidebigdata.com\"],\"url\":\"https:\/\/insidebigdata.com\/author\/editorial\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AI for Pharma R&D - Creating Anti-cancer Drugs Faster, Reducing Process from Years to Days - insideBIGDATA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/","og_locale":"en_US","og_type":"article","og_title":"AI for Pharma R&D - Creating Anti-cancer Drugs Faster, Reducing Process from Years to Days - insideBIGDATA","og_description":"The costs and process of developing anti-cancer drugs has been an extreme challenge for decades. Today one company, AccutarBio, is harnessing the power of AI to accelerate drug discovery and reform the current \"hit-to-lead\" drug discovery scheme. The company recently received $15 million in funding (including money from Chinese AI\/facial recognition company YITU) and is now partnering with Amgen.","og_url":"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/","og_site_name":"insideBIGDATA","article_publisher":"http:\/\/www.facebook.com\/insidebigdata","article_published_time":"2018-06-27T15:30:33+00:00","article_modified_time":"2018-06-28T15:49:27+00:00","og_image":[{"url":"https:\/\/insidebigdata.com\/wp-content\/uploads\/2018\/06\/AccutarBio_logo.png"}],"author":"Editorial Team","twitter_card":"summary_large_image","twitter_creator":"@insideBigData","twitter_site":"@insideBigData","twitter_misc":{"Written by":"Editorial Team","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/","url":"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/","name":"AI for Pharma R&D - Creating Anti-cancer Drugs Faster, Reducing Process from Years to Days - insideBIGDATA","isPartOf":{"@id":"https:\/\/insidebigdata.com\/#website"},"datePublished":"2018-06-27T15:30:33+00:00","dateModified":"2018-06-28T15:49:27+00:00","author":{"@id":"https:\/\/insidebigdata.com\/#\/schema\/person\/2949e412c144601cdbcc803bd234e1b9"},"breadcrumb":{"@id":"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/insidebigdata.com\/2018\/06\/27\/ai-pharma-rd-creating-anti-cancer-drugs-faster-reducing-process-years-days\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/insidebigdata.com\/"},{"@type":"ListItem","position":2,"name":"AI for Pharma R&#038;D &#8211; Creating Anti-cancer Drugs Faster, Reducing Process from Years to Days"}]},{"@type":"WebSite","@id":"https:\/\/insidebigdata.com\/#website","url":"https:\/\/insidebigdata.com\/","name":"insideBIGDATA","description":"Your Source for AI, Data Science, Deep Learning &amp; Machine Learning Strategies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/insidebigdata.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/insidebigdata.com\/#\/schema\/person\/2949e412c144601cdbcc803bd234e1b9","name":"Editorial Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/insidebigdata.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e137ce7ea40e38bd4d25bb7860cfe3e4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e137ce7ea40e38bd4d25bb7860cfe3e4?s=96&d=mm&r=g","caption":"Editorial Team"},"sameAs":["http:\/\/www.insidebigdata.com"],"url":"https:\/\/insidebigdata.com\/author\/editorial\/"}]}},"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p9eA3j-5n6","jetpack-related-posts":[{"id":15097,"url":"https:\/\/insidebigdata.com\/2016\/05\/28\/deep-learning-applied-to-drug-discovery-and-repurposing\/","url_meta":{"origin":20652,"position":0},"title":"Deep Learning Applied to Drug Discovery and Repurposing","date":"May 28, 2016","format":false,"excerpt":"In a recently accepted manuscript titled \u201cDeep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data\u201d, scientists from Insilico Medicine, Inc located at the Emerging Technology Centers at Johns Hopkins University in collaboration with Datalytic Solutions and Mind Research Network presented a novel approach applying\u2026","rel":"","context":"In &quot;Big Data&quot;","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/insidebigdata.com\/wp-content\/uploads\/2016\/05\/Insilico_Medicine_logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":13512,"url":"https:\/\/insidebigdata.com\/2015\/08\/10\/insilico-medicine-to-utilize-deep-learning-for-drug-repurposing-and-discovery-in-cancer-and-age-related-disease\/","url_meta":{"origin":20652,"position":1},"title":"Insilico Medicine to Utilize Deep Learning for Drug Repurposing and Discovery in Cancer and Age-Related Disease","date":"August 10, 2015","format":false,"excerpt":"Insilico Medicine, a bioinformatics company dedicated to drug discovery for cancer and aging, has launched its proprietary DeepPharma (TM) platform. DeepPharma utilizes the latest advances in deep learning to improve computer analysis of massive structured multi-omics data banks and millions of tissue-specific pathway activation profiles.","rel":"","context":"In &quot;Big Data&quot;","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/insidebigdata.com\/wp-content\/uploads\/2015\/08\/Insilico.jpg?resize=350%2C200","width":350,"height":200},"classes":[]},{"id":21519,"url":"https:\/\/insidebigdata.com\/2018\/11\/23\/big-data-critical-pharmaceutical-industry\/","url_meta":{"origin":20652,"position":2},"title":"Why Big Data is Critical to the Pharmaceutical Industry","date":"November 23, 2018","format":false,"excerpt":"In this special guest feature, Inga Shugalo, a Healthcare Industry Analyst at Itransition, suggests that whether it\u2019s an application for precision medicine, decreasing the failure rates in drug trials, or lowering the cost of research and developing better medicine, big data has a bright future for the pharmaceutical industry.","rel":"","context":"In &quot;Big Data&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":17362,"url":"https:\/\/insidebigdata.com\/2017\/03\/12\/4-ways-ai-changing-healthcare\/","url_meta":{"origin":20652,"position":3},"title":"4 Ways AI Is Changing Healthcare","date":"March 12, 2017","format":false,"excerpt":"In this contributed, Anthony Coggine, HR professional turned business analyst. provides four ways that artificial intelligence (AI) is changing the healthcare industry.","rel":"","context":"In &quot;AI Deep Learning&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":23324,"url":"https:\/\/insidebigdata.com\/2019\/09\/25\/human-ai-collaboration-and-autonomous-vehicle-research\/","url_meta":{"origin":20652,"position":4},"title":"Human-AI Collaboration and Autonomous Vehicle Research","date":"September 25, 2019","format":false,"excerpt":"It's wonderful to see when members of the big data ecosystem team up large industry players for some late-breaking research results. Case in point, our friends over at DarwinAI recently revealed significant research results in a joint paper with German auto manufacturer Audi. The paper is titled \"Human-Machine Collaborative Design\u2026","rel":"","context":"In &quot;AI Deep Learning&quot;","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/insidebigdata.com\/wp-content\/uploads\/2019\/09\/DarwinAI_research_paper.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":20115,"url":"https:\/\/insidebigdata.com\/2018\/03\/25\/optalysys-demonstrates-optical-processing-technology-performing-deep-learning\/","url_meta":{"origin":20652,"position":5},"title":"Optalysys Demonstrates its Optical Processing Technology Performing Deep Learning","date":"March 25, 2018","format":false,"excerpt":"Optalysys Ltd., an innovative technology company commercializing light-speed optical coprocessors for AI\/Deep Learning announced they had successfully built the world\u2019s first implementation of a Convolutional Neural Network using their Optical Processing Technology.","rel":"","context":"In &quot;AI Deep Learning&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/insidebigdata.com\/wp-json\/wp\/v2\/posts\/20652"}],"collection":[{"href":"https:\/\/insidebigdata.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/insidebigdata.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/insidebigdata.com\/wp-json\/wp\/v2\/users\/10513"}],"replies":[{"embeddable":true,"href":"https:\/\/insidebigdata.com\/wp-json\/wp\/v2\/comments?post=20652"}],"version-history":[{"count":0,"href":"https:\/\/insidebigdata.com\/wp-json\/wp\/v2\/posts\/20652\/revisions"}],"wp:attachment":[{"href":"https:\/\/insidebigdata.com\/wp-json\/wp\/v2\/media?parent=20652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/insidebigdata.com\/wp-json\/wp\/v2\/categories?post=20652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/insidebigdata.com\/wp-json\/wp\/v2\/tags?post=20652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}